Core Laboratories (NYSE: CLB) reported Q1 EPS of $0.42, $0.03 better than the analyst estimate of $0.39. Revenue for the quarter came in at $158 million versus the consensus estimate of $150.57 million.

GUIDANCE:

Core Laboratories sees Q2 2017 EPS of $0.48-$0.52, versus the consensus of $0.48.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.